ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

27,337Medicare Part D Prescriptions Filled, Including Refills

Rank: 31 out of 2888

$1.53M Total Retail Price of All Prescriptions

Rank: 66 out of 2888

972 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
63% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 972 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

22% of this provider’s 972 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 20,787 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
SIMVASTATIN 1,074 909 1 2
HYDROCODONE-ACETAMINOPHEN 793 366 S3 2 4
LISINOPRIL 781 652 3 3
METOPROLOL TARTRATE 700 585 4 10
AMLODIPINE BESYLATE 660 508 5 5
LISINOPRIL-HYDROCHLOROTHIAZIDE 658 500 6 28
LEVOTHYROXINE SODIUM 650 546 7 1
OMEPRAZOLE 597 484 8 7
METFORMIN HCL 566 374 9 8
FUROSEMIDE 563 416 10 6
METOPROLOL SUCCINATE 548 465 11 11
CRESTOR 496 354 12 20
TRAMADOL HCL 479 349 13 16
GABAPENTIN 457 294 14 13
POTASSIUM CHLORIDE 406 308 15 14
CITALOPRAM HBR 360 315 16 24
HYDRALAZINE HCL 338 259 17 59
LOSARTAN POTASSIUM 325 292 18 18
ATORVASTATIN CALCIUM 320 287 19 9
FLUTICASONE PROPIONATE 313 246 20 32
PREDNISONE 278 191 21 42
GLIPIZIDE ER 274 206 22 107
MELOXICAM 252 218 23 31
LANTUS 240 198 24 45
WARFARIN SODIUM 235 198 25 22
PRAVASTATIN SODIUM 230 154 26 12
SERTRALINE HCL 230 185 26 27
TRAZODONE HCL 226 179 28 43
TERAZOSIN HCL 224 182 29 152
TAMSULOSIN HCL 216 189 30 29
JANUVIA 209 144 31 48
DONEPEZIL HCL 204 183 32 26
METHOCARBAMOL 203 132 R 33 176
CARVEDILOL 197 137 34 21
QUETIAPINE FUMARATE 195 180 35 66
GLIPIZIDE 191 162 36 50
RAMIPRIL 189 158 37 73
MIRTAZAPINE 184 180 38 54
NAMENDA 183 160 39 34
CIPROFLOXACIN HCL 181 130 40 47
NIASPAN 174 96 41 127
NIFEDIPINE ER 167 136 42 76
CYMBALTA 166 123 43 44
ALLOPURINOL 164 119 44 37
HYDROCHLOROTHIAZIDE 160 129 45 15
PROAIR HFA 159 67 46 71
GLIPIZIDE XL 156 119 47 205
LACTULOSE 153 113 48 111
NEXIUM 150 83 49 19
LEVETIRACETAM 144 94 50 103
ATENOLOL 143 139 51 25
NIFEDICAL XL 140 136 52 190
ENALAPRIL MALEATE 140 96 52 49
CARBINOXAMINE MALEATE 137 115 R 10 54 427
METOCLOPRAMIDE HCL 130 95 55 116
SINGULAIR 127 97 56 85
CYCLOBENZAPRINE HCL 115 68 R 57 68
OXYBUTYNIN CHLORIDE 111 83 58 124
NOVOLIN R 110 87 59 109
CLOPIDOGREL 110 91 59 30
SULFAMETHOXAZOLE-TRIMETHOPRIM 109 78 61 88
FLUOXETINE HCL 107 53 62 83
LYRICA 105 65 63 69
DIGOXIN 105 95 63 55
AMOXICILLIN 105 72 63 117
ADVAIR DISKUS 103 63 66 60
CLONIDINE HCL 100 71 67 39
ESCITALOPRAM OXALATE 100 68 67 62
ZETIA 100 83 67 81
RANITIDINE HCL 100 60 67 56
PROMETHAZINE HCL 99 71 R 71 96
KLOR-CON M10 97 59 72 118
LOVASTATIN 94 74 73 41
NYSTATIN 92 71 74 178
BUMETANIDE 91 72 75 203
ALENDRONATE SODIUM 90 69 76 23
METHADONE HCL 90 22 S2 76 216
IPRATROPIUM-ALBUTEROL 90 82 76 150
VENLAFAXINE HCL ER 90 56 76 120
VERAPAMIL ER 85 62 80 104
FINASTERIDE 85 77 80 102
IBUPROFEN 84 44 82 87
PAROXETINE HCL 84 60 82 84
AMITRIPTYLINE HCL 83 48 R 84 74
DIOVAN 83 68 84 35
PANTOPRAZOLE SODIUM 82 73 86 33
HUMULIN R 81 72 87 233
KLOR-CON M20 80 59 88 90
MONTELUKAST SODIUM 80 56 88 153
ZOLPIDEM TARTRATE 79 35 90 17
SPIRIVA 79 61 90 79
LOSARTAN-HYDROCHLOROTHIAZIDE 78 65 92 46
MECLIZINE HCL 77 70 93 122
GEMFIBROZIL 77 63 93 98
ISOSORBIDE MONONITRATE ER 76 53 95 51
RISPERIDONE 73 66 96 72
PLAVIX 73 59 96 40
CLONIDINE 70 63 98 247
GLIMEPIRIDE 70 53 98 36
AZITHROMYCIN 68 52 100 38
TRAMADOL HCL-ACETAMINOPHEN 68 67 100 95
GLYBURIDE 65 55 R 102 58
BYSTOLIC 64 60 103 99
AMIODARONE HCL 63 54 104 167
TRICOR 61 49 105 91
PHENYTOIN SODIUM EXTENDED 60 39 106 128
CARISOPRODOL 60 14 R 106 82
ARBINOXA 59 36 10 108 554
HYDROCORTISONE 59 40 108 362
ABILIFY 57 50 110 172
POLYETHYLENE GLYCOL 3350 55 46 111 93
INSULIN SYRINGE 54 40 112 86
AMLODIPINE BESYLATE-BENAZEPRIL 53 36 113 67
SUCRALFATE 53 51 113 187
SEROQUEL 52 47 115 143
AMITIZA 52 38 115 296
COMBIVENT 51 27 117 177
HUMALOG 51 43 117 166
BUSPIRONE HCL 51 39 117 148
LEVOFLOXACIN 51 42 117 57
GLYBURIDE-METFORMIN HCL 50 41 R 121 64
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 22, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.